about
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include S...
Read More
0.18
0.00
(0.00%)
17.0M
XNAS Volume
XNAS 10 Aug, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Gossamer Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..